Skip to content

Medicated vs Unmedicated IUI: Which One You're Doing and Why

A doctor's breakdown of medicated vs unmedicated IUI success rate, what each protocol involves, the per-cycle math, and when natural-cycle IUI is rational.

Reviewed May 18, 202617 min read
By Pairceive Editorial Team /Reviewed by Dr. Rumpa
Medicated vs Unmedicated IUI: Which One You're Doing and Why

Your RE has just said "we'll do a medicated cycle" without much context, or you are choosing between a natural-cycle IUI and a letrozole cycle for cost or simplicity reasons. The question worth answering is what each protocol actually involves, how the per-cycle numbers differ, and when a natural cycle is genuinely a better fit than a medicated one. The medicated vs unmedicated IUI success rate is not a single number; it is three different conversations depending on your diagnosis.

The short version. Medicated IUI outperforms unmedicated IUI on a per-cycle basis in most diagnoses. The size of the bump, the meds involved, and the trade-offs in monitoring, side effects, and twin risk differ between PCOS, unexplained infertility, and donor-sperm cycles. For some readers, natural-cycle IUI is the right starting protocol. For others, skipping the meds is leaving probability on the table for no good reason. The rest of this post is how to tell which group you are in.

What "medicated" and "unmedicated" actually mean

The terms are used loosely in forums and even in clinic, so let me put precise definitions on them.

Unmedicated (natural cycle) IUI: your own ovulation drives the cycle. The LH surge is detected by ovulation predictor kits at home, by bloodwork at the clinic, or by both. A single egg ovulates. No oral or injectable fertility medications are used to stimulate the cycle. The IUI itself is timed to the surge, typically 24 to 36 hours after a positive OPK.

Medicated IUI with oral agents: letrozole or clomid is taken for five days, usually days 3 through 7 or days 5 through 9 of the cycle. The medication drives follicle development. A transvaginal ultrasound around cycle day 10 to 12 confirms one to two mature follicles. A trigger shot of hCG (Ovidrel or Pregnyl) is administered to time ovulation, and the IUI is scheduled 24 to 36 hours later. This is the most common modern IUI protocol.

Stimulated (gonadotropin) IUI: injectable FSH (Gonal-F, Follistim, Menopur) drives follicle development. Higher response, higher per-cycle pregnancy, but significantly higher multiple-pregnancy risk. Most US clinics have moved away from gonadotropin-IUI for safety reasons, and the ASRM 2020 committee opinion on gonadotropins recommends reserving it for specific refractory cases at clinics willing to manage the multiple-pregnancy risk.3 Gonadotropin-IUI is uncommon enough in 2026 that I will not dwell on it in this post.

Two other protocol additions get confused with "medicated." A trigger shot used in a natural cycle to time the LH surge does not by itself make the cycle a medicated one in the sense most people mean. Progesterone added in the luteal phase is a supplement, not the cycle stimulation. When clinicians say "medicated IUI," they almost always mean an oral agent or gonadotropins driving follicle development.

Medicated vs unmedicated IUI success rate: the numbers

The unmedicated IUI success rate is one of the more clearly studied numbers in the literature. Across published series, the per-cycle live birth in unmedicated IUI for unexplained infertility under 35 sits in the 4 to 8 percent range. The Cochrane review of IUI versus timed intercourse and the Cohlen 2018 systematic review in Human Reproduction Update both support this band.4^,6

Letrozole or clomid + IUI in unexplained infertility, the most common protocol in modern US practice, runs in the 8 to 12 percent per cycle range. The FAST-T/AMIGOS trial (Diamond 2015, NEJM) reported per-cycle pregnancy rates of 8.6 percent for letrozole-IUI and 9.0 percent for clomid-IUI across four cycles in unexplained infertility couples.1

Gonadotropin + IUI ran higher in the same FAST-T trial, at 17.5 percent per cycle, but with a 32 percent multiple-pregnancy rate. That multiple rate is the reason gonadotropin-IUI is rarely the default in modern US practice.1^,3

In PCOS, letrozole-IUI clearly outperforms clomid-IUI on live birth (the PALM/PPCOS-II trial, Legro 2014, NEJM).2 Letrozole is first-line for PCOS per ASRM and the 2023 international PCOS guideline (Teede).7

In donor-sperm cycles in recipients without female-factor infertility, medicated cycles add a smaller per-cycle bump than they do in unexplained infertility, often not enough to justify the additional cost and monitoring. Many clinics start donor-sperm IUI as natural cycles for this reason.

In one summary: medicated IUI roughly doubles the per-cycle live birth versus unmedicated IUI in unexplained infertility. It modestly outperforms unmedicated IUI in PCOS once ovulation is achieved. It adds less value in donor-sperm cycles where there is no female-factor barrier.

The iui with one follicle success rate question

Most medicated cycles produce a single dominant follicle on letrozole, which is what makes letrozole a relatively physiologic agent compared with clomid or gonadotropins. The iui with one follicle success rate searches usually surface here, and the answer matches the per-cycle live-birth ranges I have already given. A single mature follicle is the baseline, and per-cycle live birth in someone under 35 with a normal partner sample on letrozole-IUI sits at roughly 10 to 18 percent.

Two follicles modestly improves the per-cycle pregnancy and meaningfully raises twin risk to roughly 15 percent. Three or more is the threshold where most modern clinics will cancel the cycle and convert to abstinence rather than accept the multiples risk. Merviel and colleagues' analysis of more than a thousand IUI cycles is one of the cleanest breakdowns of how follicle count translates to per-cycle pregnancy and to twin risk.

What this means practically. A "good" letrozole-IUI cycle is not always two follicles. One mature follicle with a normal endometrium and a normal partner sample is a solid cycle. A clinic that drives toward two or three follicles to "boost odds" is making a different risk trade-off than one that targets one to two.

When each protocol makes sense

The protocol choice should map to your indication, not to your preferences or your clinic's defaults.

Natural-cycle IUI is the better fit when:

  • You are using donor sperm and have no female-factor infertility, with regular cycles
  • Mild male-factor infertility or cervical-factor infertility in a regularly ovulating partner
  • Cost is a real constraint and you have agreed with your clinic on a limited-cycle plan
  • You have had intolerable side effects on letrozole or clomid in a prior cycle
  • A diagnostic first cycle ("can we see her ovulate cleanly and inseminate on the right day before adding meds?")

Letrozole or clomid + IUI is the better fit when:

  • Unexplained infertility (AMIGOS supports either, with letrozole and clomid roughly equivalent at around 9 percent per cycle)1
  • PCOS: letrozole first-line per PALM and the 2023 PCOS guideline2^,7
  • Mild male-factor infertility where adding a second follicle increases the per-cycle odds enough to justify the twin-risk trade-off
  • Regularly ovulating women whose RE is trying to "boost odds" through stimulation. This one deserves a question rather than a default acceptance. Stimulating an already-ovulatory cycle adds twin risk and side effects without a clear evidence base for benefit in some cohorts; ask the reasoning.

Gonadotropin + IUI is rarely the right tool in 2026 outside selected refractory unexplained cases at clinics willing to manage the multiples risk strictly. Cancellation thresholds (three or more mature follicles) need to be explicit before the cycle starts. The ASRM 2020 committee opinion is the relevant guideline.3

Medicated vs Unmedicated IUI: Which One You're Doing and Why: infographic
At a glance: Medicated vs Unmedicated IUI: Which One You're Doing and Why

Trade-offs you take with medications

The per-cycle bump from medication is not free. The trade-offs are worth naming directly.

Letrozole side effects: hot flashes in roughly 30 percent of cycles. Fatigue, mild dizziness, mild headache. The half-life is short (about two days), so side effects clear quickly after the five-day course. Most patients tolerate letrozole well. Bone-density concerns from long-term use do not apply to the short courses used in fertility treatment.

Clomid side effects: more substantial in most patients. Hot flashes in roughly 50 percent. Mood changes, sometimes significant. Visual changes are rare but warrant immediate clinical contact (clomid should be stopped). The antioestrogenic effects on the endometrium and cervical mucus, which I mentioned earlier, are part of the reason letrozole has moved to first line in many clinics. Clomid is also officially limited to a maximum of six lifetime cycles by most guidelines, though the cumulative cap matters less in modern practice because most patients move to other protocols before reaching it.

Monitoring burden: medicated cycles need at least one mid-cycle follicle check by transvaginal ultrasound and an estradiol or LH measurement. Some clinics scan twice. Natural cycles can sometimes be managed with OPK alone, with the IUI scheduled by the LH surge at home. The difference matters if you live far from the clinic or have a job that does not flex around clinic appointments.

Twin risk: roughly 6 to 10 percent with letrozole or clomid + IUI. Up to 30 percent with gonadotropin-IUI. Background twin rate is around 1 percent. The clomid and IUI success rate searches sometimes do not include the twin-rate data; it is the second number worth knowing.

Cost: what to expect

The medicated vs unmedicated IUI cost differential is meaningful but not enormous in most US markets.

Natural IUI cycles typically run $500 to $1,500 in US clinics, with less monitoring driving the lower end. Letrozole or clomid + IUI cycles typically run $1,500 to $3,000 per cycle, with the medication itself being relatively inexpensive (letrozole is available generically; clomid is similarly generic). The cost difference is driven mainly by additional monitoring visits and the trigger shot. Gonadotropin-IUI cycles run $3,000 to $5,000 per cycle, with the injectable medications driving the cost. The full breakdown across protocols is in iui-cost-per-cycle.

The UK NHS pathway differs by region, and private IUI in the UK typically runs £700 to £1,600 per cycle.

Special cases

A few cohorts deserve specific framing.

PCOS: medicated IUI is the default. Your ovulation needs medication assistance, and the choice is letrozole versus clomid (letrozole wins on the PALM data), not medicated versus unmedicated.2

Anovulatory cycles in non-PCOS patients: medicated IUI is almost always the right tool, for the same reason. If you are not ovulating reliably, an unmedicated IUI has nothing to target.

Same-sex female couples and single people using donor sperm: natural-cycle IUI is a rational starting protocol if cycles are regular and there is no female-factor infertility. Ask the clinic for both option pricings and stick with natural unless something specific argues against it.

Age 35 to 37 with unexplained infertility: letrozole-IUI for two to three cycles is the typical ladder before reassessing. The bump from medication is meaningful at this age.

Age 38 and over with unexplained infertility: the FORT-T trial showed faster-to-IVF improved time-to-pregnancy in 38- to 42-year-olds compared with the standard IUI-first ladder.5 If you are doing IUI in this age band, letrozole-IUI for one to two cycles is the more common pattern before pivoting to IVF, and natural-cycle IUI is rarely the right starting protocol here.

Questions to ask your RE

Five questions to bring into the protocol conversation.

  1. Why are we choosing this protocol over the other, given my age and diagnosis?
  2. What is the target follicle count, and what is the cancellation threshold?
  3. What is my expected per-cycle live birth on this protocol?
  4. What is the twin risk on this protocol for someone in my situation?
  5. If cycle 1 does not work, what changes for cycle 2? Some of this is covered in second-iui-what-changes.

A clinic that can answer these clearly is thinking about your cycle individually. A clinic that defaults without these answers is one to push.

What you can do this cycle

Two practical pieces.

If your protocol is letrozole or clomid, know which medication and on which cycle days. Take the dose at the same time daily, often before bed if you tolerate hot flashes better that way. Hot flashes that wake you at night are common in the first 48 hours; they pass.

If your protocol is a natural cycle, the variable you can affect is the timing precision. LH-surge detection with a digital OPK or a quantitative app, started on cycle day 9 to 10 in someone with regular cycles, gives you the cleanest signal. A positive OPK 24 hours before insemination is the standard target. Some clinics combine OPK at home with a confirming bloodwork visit; ask what the workflow will be. The medicated vs unmedicated IUI success rate gap is real, but the cycle that runs well on its chosen protocol matters more than the protocol label.

What's next

Sources

  1. Diamond MP, Legro RS, Coutifaris C, et al. Letrozole, gonadotropin, or clomiphene for unexplained infertility (AMIGOS/FAST-T). New England Journal of Medicine 2015;373(13):1230-1240. Link
  2. Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome (PPCOS-II/PALM). New England Journal of Medicine 2014;371(2):119-129. Link
  3. Practice Committee of the American Society for Reproductive Medicine. Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion. Fertility and Sterility 2020;113(1):66-70. Link
  4. Cohlen B, Bijkerk A, Van der Poel S, Ombelet W. IUI: review and systematic assessment of the evidence that supports global recommendations. Human Reproduction Update 2018;24(3):300-319. Link
  5. Reindollar RH, Regan MM, Neumann PJ, et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the Fast Track and Standard Treatment (FASTT) trial. Fertility and Sterility 2010;94(3):888-899. Link
  6. Veltman-Verhulst SM, Hughes E, Ayeleke RO, Cohlen BJ. Intra-uterine insemination for unexplained subfertility. Cochrane Database of Systematic Reviews 2016;(2):CD001838. Link
  7. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertility and Sterility 2023;120(4):767-793. Link

Common questions

What is the difference between medicated and unmedicated IUI?

In unmedicated (natural cycle) IUI, your own ovulation drives the cycle and a single egg ovulates, with no oral or injectable medications used to stimulate it. In medicated IUI, an oral agent like letrozole or clomid (or, less commonly, injectable gonadotropins) drives follicle development. A trigger shot of hCG often times ovulation, with the IUI scheduled 24 to 36 hours later.

Is medicated IUI more successful than unmedicated IUI?

On a per-cycle basis, medicated IUI outperforms unmedicated IUI in most diagnoses. In unexplained infertility it roughly doubles the per-cycle live birth, moving from a 4 to 8 percent range unmedicated to 8 to 12 percent with letrozole or clomid. It adds less value in donor-sperm cycles where there is no female-factor barrier.

Can you get pregnant with only one follicle on a medicated IUI cycle?

Yes. Most letrozole cycles produce a single dominant follicle, and one mature follicle with a normal endometrium and a normal partner sample is a solid cycle. Per-cycle live birth in someone under 35 on letrozole-IUI sits at roughly 10 to 18 percent. A good cycle is not always two follicles.

When is natural-cycle IUI the better choice?

Natural-cycle IUI is a rational fit when you are using donor sperm with no female-factor infertility and regular cycles, for mild male-factor or cervical-factor infertility in a regularly ovulating partner, when cost is a real constraint under a limited-cycle plan, after intolerable side effects on letrozole or clomid, or as a diagnostic first cycle.

What is the twin risk with medicated IUI?

Twin risk runs roughly 6 to 10 percent with letrozole or clomid plus IUI, compared with a background twin rate of around 1 percent. Two follicles meaningfully raises twin risk to roughly 15 percent, and gonadotropin-IUI can reach up to 30 percent. Most modern clinics cancel the cycle at three or more mature follicles rather than accept the multiples risk.